ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood clot drug trial for rare autoimmune disease pulled before start
Disease control TerminatedThis study aimed to test if crovalimab, added to standard blood thinners, could prevent dangerous blood clots in people with antiphospholipid syndrome (APS). APS is an autoimmune condition that raises the risk of clots. The trial was planned for adults aged 18–70 with at least tw…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Rare disease pregnancy study withdrawn before start
Knowledge-focused TerminatedThis study was designed to track pregnancies in women with rare autoimmune diseases like lupus, arthritis, and scleroderma. The goal was to learn about complications and improve care. However, the study was withdrawn before enrolling any participants, so no results are available.
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC